Notice2023-07570
National Cancer Institute; Amended Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 11, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 69 (Tuesday, April 11, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 69 (Tuesday, April 11, 2023)]
[Notices]
[Page 21693]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-07570]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Institute Special Emphasis Panel, SEP-1: NCI Clinical and
Translational Cancer Research, June 1, 2023, 10:00 a.m. to 5:00 p.m.,
National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room
7W108, Rockville, Maryland 20850 which was published in the Federal
Register on April 06, 2023, FR Doc 2023-07213, 88 FR 20542.
This notice is being amended to change the meeting date from June
1, 2023 to June 8, 2023. Meeting times and location will stay the same.
The meeting is closed to public.
Dated: April 6, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-07570 Filed 4-10-23; 8:45 am]
BILLING CODE 4140-01-P
</pre></body>
</html>Indexed from Federal Register on April 11, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.